000 | 01260 a2200349 4500 | ||
---|---|---|---|
005 | 20250515042602.0 | ||
264 | 0 | _c20061024 | |
008 | 200610s 0 0 eng d | ||
022 | _a1744-8360 | ||
024 | 7 |
_a10.1586/14737175.6.9.1337 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHol, Elly M | |
245 | 0 | 0 |
_aUbiquitin proteasome system as a pharmacological target in neurodegeneration. _h[electronic resource] |
260 |
_bExpert review of neurotherapeutics _cSep 2006 |
||
300 |
_a1337-47 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Neurological |
650 | 0 | 4 |
_aNeurodegenerative Diseases _xdrug therapy |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
650 | 0 | 4 |
_aProteasome Endopeptidase Complex _xdrug effects |
650 | 0 | 4 |
_aUbiquitin _xmetabolism |
700 | 1 | _aFischer, David F | |
700 | 1 | _aOvaa, Huib | |
700 | 1 | _aScheper, Wiep | |
773 | 0 |
_tExpert review of neurotherapeutics _gvol. 6 _gno. 9 _gp. 1337-47 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1586/14737175.6.9.1337 _zAvailable from publisher's website |
999 |
_c16587635 _d16587635 |